Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caulophyllum thalictroides is a homeopathic preparation derived from the roots of the blue cohosh plant. Developed and manufactured by Boiron, it is primarily used in the fields of gynecology and obstetrics. In clinical practice, it is often administered as sublingual pellets at various potencies, such as 9CH. It has been investigated in Phase 3 clinical trials, often in combination with Actaea racemosa, to evaluate its efficacy in shortening the duration of the first stage of labor. Beyond obstetrics, it is traditionally used for menstrual cramps, premenstrual syndrome (PMS), and rheumatic pain in small joints. As a homeopathic product, its mechanism of action does not involve conventional pharmacological targets, and its clinical efficacy remains a subject of debate due to the high level of dilution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caulophyllum thalictroides.